Share This Link

This client has newly diagnosed heart failure and worsening symptoms of fluid overload, including dyspnea, crackles, edema, elevated BNP, and decreased oxygen saturation. Heart failure management aims to reduce preload and afterload, improve cardiac output, and prevent fluid retention. Medication selection and monitoring are critical, especially regarding renal function and electrolyte balance. Nursing care must align with standard heart failure pharmacologic therapy and avoid interventions that worsen fluid retention or electrolyte disturbances.

Rationale:

• Spironolactone 50 mg PO once daily: Spironolactone is a potassium-sparing diuretic and aldosterone antagonist used in heart failure to reduce fluid overload and cardiac remodeling. It helps decrease mortality in patients with symptomatic heart failure. The client shows signs of volume overload, including edema, crackles, and elevated BNP. Therefore, this medication is appropriate for managing fluid retention and improving outcomes.

• Obtain BUN and creatinine: Renal function must be monitored closely in heart failure due to the risk of impaired perfusion and medication effects on the kidneys. Diuretics and ACE inhibitors can alter renal function and electrolyte balance. Elevated fluid status and decreased cardiac output can further compromise kidney perfusion. Monitoring BUN and creatinine is essential for safe treatment planning.

• Enalapril 2.5 mg PO twice daily: Enalapril is an ACE inhibitor that reduces afterload, improves cardiac output, and decreases progression of heart failure. It also helps reduce mortality and hospitalizations in heart failure clients. The client demonstrates elevated blood pressure and symptoms of worsening heart failure, making ACE inhibitor therapy appropriate. It is a first-line medication in this condition.

• Albuterol dry powder inhaler, inhale 2 puffs every 4 to 6 hr PRN shortness of breath: Albuterol is a bronchodilator used primarily for obstructive airway diseases such as asthma or COPD, not heart failure. The client’s respiratory symptoms are due to pulmonary congestion, not bronchospasm. Using albuterol would not address the underlying fluid overload and may cause tachycardia, worsening cardiac workload.

• Fluid restriction of 0.5 L per day: A fluid restriction of 0.5 L (500 mL) per day is excessively restrictive and unsafe for most heart failure clients. While fluid restriction may be necessary, typical limits are individualized and generally higher (e.g., 1.5–2 L/day depending on severity). Severe restriction can lead to dehydration, renal impairment, and electrolyte imbalance.

• Potassium 20 mEq PO twice daily: Potassium supplementation is not indicated because the client’s potassium level is normal (4.5 mEq/L). Additionally, the client is prescribed spironolactone and an ACE inhibitor, both of which increase potassium levels and raise the risk of hyperkalemia. Adding potassium supplementation could lead to dangerous cardiac dysrhythmias. Therefore, this prescription is contraindicated.

This question focuses on identifying critical findings in a client with type 1 diabetes mellitus who is presenting with severe hyperglycemia, infection, and metabolic acidosis. The client shows signs consistent with diabetic ketoacidosis (DKA) and concurrent pneumonia, both of which can rapidly become life-threatening. DKA is characterized by insulin deficiency leading to hyperglycemia, ketone production, dehydration, and metabolic acidosis. Immediate follow-up is required for findings indicating respiratory compensation, hemodynamic instability, and worsening acid-base imbalance.

Rationale for correct findings:

• Blood pressure: A decreasing blood pressure (from 118/72 mmHg to 108/68 mmHg) suggests early circulatory compromise likely due to dehydration from osmotic diuresis in DKA. Fluid losses from hyperglycemia cause intravascular volume depletion. This can progress to hypovolemic shock if not corrected. Therefore, blood pressure trends require urgent monitoring.

• Heart rate: An elevated heart rate reflects the body’s compensatory response to dehydration and decreased circulating volume in DKA. Tachycardia occurs as the body attempts to maintain cardiac output despite fluid loss from osmotic diuresis. It may also indicate systemic infection from pneumonia. Persistent tachycardia signals worsening physiologic stress.

• Pulse is rapid: A rapid pulse reinforces the presence of compensatory cardiovascular response to hypovolemia and metabolic stress. In DKA, fluid loss leads to reduced preload and increased sympathetic stimulation. This results in a bounding or rapid pulse as the body attempts to maintain perfusion. It is an early warning sign of circulatory instability.

• Respiratory rate: An increased respiratory rate indicates compensatory mechanisms for metabolic acidosis. In DKA, the body increases ventilation (Kussmaul respirations) to blow off carbon dioxide and raise pH. A rising respiratory rate signals worsening acidosis. This is a key indicator of metabolic decompensation.

• Respirations deep and rapid with fruity breath odor: Deep, rapid (Kussmaul) respirations combined with fruity breath odor indicate ketone accumulation and metabolic acidosis. The fruity odor results from acetone, a ketone body. This is a hallmark sign of diabetic ketoacidosis. It requires urgent intervention with insulin and fluid replacement.

• Rhonchi in right lung with frequent nonproductive cough: Rhonchi and cough suggest pneumonia, which is the likely precipitating infection for DKA. Infection increases metabolic demand and worsens insulin resistance. Pneumonia in a diabetic client can rapidly destabilize glucose control. This finding requires immediate treatment with antibiotics and respiratory support.

• ABGs: ABGs show metabolic acidosis (pH 7.32, HCO₃ 19 mEq/L) with respiratory compensation (low PCO₂). This confirms diabetic ketoacidosis. Worsening acid-base imbalance can lead to altered mental status and cardiac instability. ABG abnormalities require urgent correction through insulin and fluids.

• Urine ketones: Positive urine ketones confirm fat breakdown due to insulin deficiency. Ketone accumulation contributes to metabolic acidosis and toxicity. This is a direct indicator of diabetic ketoacidosis severity. Monitoring ketones is essential to evaluate response to therapy.

Rationale for incorrect findings:

• S1, S2 heard on auscultation: Normal S1 and S2 heart sounds indicate that there is no immediate evidence of abnormal valvular function or acute structural cardiac compromise. In diabetic ketoacidosis, the primary cardiovascular concern is usually related to volume depletion rather than intrinsic heart sound changes. Clear heart sounds do not reflect worsening metabolic acidosis or infection severity.

• Capillary refill less than 2 seconds: A capillary refill of less than 2 seconds indicates adequate peripheral perfusion at the time of assessment. This suggests that, despite dehydration risk in diabetic ketoacidosis, tissue perfusion has not yet significantly deteriorated. It does not reflect the severity of metabolic acidosis or infection. Therefore, this is a reassuring finding and not a priority indicator of clinical worsening.